WHO PROFITS FROM HERBAL MEDICINE
One of the unslayable myths about the use of alternative medicine is that it allows the user to avoid the influence of the pharmaceutical industry.  As the following article illustrates, the dollars spent on herbal medicine flow into the very same pockets; the only difference is that proof of safety and effectiveness are not required for herbs.

Acquisitions Of Botanical Companies by Multinational Pharmaceutical Companies

From: 'The European Phytomedicines Market: Figures, Trends and Analyses,' by Jarg Grunwald, Lichtwer Pharma GmbH, Berlin Germany, in HerbalGram 34, 60 (1995)
Published in Pharmaceutical News, Vol 2, No. 1,  Jan-Feb. 1996
 
 
 
PARENT PHARMACEUTICAL CORPORATION
NATURAL MEDICINE COMPANY
American Home Products Dr. Much (Germany) 
Boehringer Ingelheim Pharmaton (Switzerland) & Quest (Canada)
Boots Kanold (Germany)
Bausch & Lomb Dr. Mann (Germany)
Degussa Asta Medica (Germany)
Fujisawa Klinge (Germany)
Johnson & Johnson/Merck Woelm Pharma (Germany)
Pfizer Mack (Germany)
Rhone-Poulenc Rohrer Nattermann (Germany)
Sanofi Plantorgan(Germany)
Searle Heumann (Germany)
SmithKline Beecham Fink (Germany)
Solvay KaliChemis